| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.25B | 7.81B | 6.96B | 7.30B | 6.30B | 4.78B |
| Gross Profit | 3.64B | 3.41B | 2.99B | 1.45B | 2.53B | 2.05B |
| EBITDA | 1.55B | 1.45B | 1.35B | 1.37B | 1.22B | 957.35M |
| Net Income | 664.20M | 605.52M | 665.86M | 804.31M | 636.55M | 479.56M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 9.37B | 8.20B | 6.96B | 5.74B | 4.36B |
| Cash, Cash Equivalents and Short-Term Investments | 18.46M | 100.09M | 3.06M | 48.82M | 41.20M | 5.35M |
| Total Debt | 0.00 | 1.76B | 1.26B | 473.70M | 444.05M | 1.08B |
| Total Liabilities | -6.38B | 2.99B | 2.25B | 1.37B | 1.17B | 1.81B |
| Stockholders Equity | 6.38B | 6.38B | 5.94B | 5.59B | 4.57B | 2.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -334.47M | -690.35M | 43.58M | -539.70M | 10.58M |
| Operating Cash Flow | 0.00 | 1.10B | 788.17M | 1.52B | 19.79M | 605.35M |
| Investing Cash Flow | 0.00 | -1.36B | -1.43B | -1.41B | -547.98M | -508.79M |
| Financing Cash Flow | 0.00 | 254.79M | 594.63M | -101.75M | 565.09M | -95.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹36.55B | 22.64 | ― | 0.49% | -7.43% | 8.03% | |
61 Neutral | ₹17.08B | 9.19 | ― | 2.38% | 47.79% | 74.12% | |
60 Neutral | ₹11.22B | 12.58 | ― | 1.21% | 0.69% | -7.54% | |
59 Neutral | ₹23.13B | 34.12 | ― | 0.65% | 15.51% | 7.88% | |
55 Neutral | ₹10.58B | -52.70 | ― | 2.08% | 4.65% | -127.24% | |
45 Neutral | ₹17.46B | 44.02 | ― | ― | ― | ― |
Mold-Tek Packaging Limited reported a significant financial performance for the quarter and half-year ended September 30, 2025, with sales increasing by 16.05% and EBITDA rising by 22.72% compared to the previous year. The company’s pharma packaging segment showed exceptional growth, with sales increasing by 45% in Q2 over Q1, highlighting its potential as a key driver for future growth and profitability.
Mold-Tek Packaging Limited has released its investor presentation for the quarter and half year ending September 30, 2025. This presentation, shared in compliance with regulatory requirements, provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
Mold-Tek Packaging Limited has announced a conference call scheduled for October 29, 2025, to discuss its Q2FY26 financial results. This call, featuring insights from the company’s Chairman and Managing Director, J Lakshmana Rao, is expected to provide stakeholders with important updates on the company’s performance and strategic direction.
Mold-Tek Packaging Limited has announced a scheduled meeting with PineBridge Investments on September 26, 2025, in Hyderabad. The meeting aims to engage with investors and analysts, adhering to SEBI regulations, without disclosing any unpublished price-sensitive information, reflecting the company’s commitment to transparency and investor relations.
Mold-Tek Packaging Limited has announced the publication of a newspaper advertisement regarding the notice of its 28th Annual General Meeting and e-voting instructions. This announcement is in compliance with the Securities and Exchange Board of India’s regulations, ensuring transparency and accessibility for its stakeholders.